Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma

Marsha L. Frazier, Nikhil Inamdar, Silpa Alvula, Elsie Wu, Yeul Hong Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Elongation factor-1 (EF-1) γ is overexpressed in a high proportion of gastrointestinal cancers. The mechanism of overexpression has not been determined. The purpose of this study was to examine cDNA specimens from pancreatic and colorectal cancer for mutation in this gene, which would allow us to determine whether gene mutations are responsible for overexpression of EF-1γ. In one colorectal carcinoma, we detected an A→G transition at amino- acid codon 158 (T→C in the sense strand) resulting in a change from a leucine to a serine. The base change was not detected in cDNA isolated from normal-appearing tissue from the same patient. We did not find mutations in another five colorectal carcinoma and five pancreatic cancer samples. Thus, although we detected a mutation in one tumor, the frequency of mutations was too low to account for the high frequency of overexpression of the EF-1γ RNA in colorectal cancer. We also investigated other possible mechanisms of overexpression of the EF-1γ RNA in this study. Slot-blot analysis of DNA isolated from colorectal cancers showed that the overexpression was not due to gene amplification. Using serum starvation to synchronize cultured cells, we showed that the overexpression was also not due to an increase in the number of cycling cells, as occurs in cancer. Using Southern blot analysis, we were unable to detect genome rearrangements that could have been responsible for the overexpression. In conclusion, the mechanism for overexpression of the EF-1γ, gene in colorectal and pancreatic cancer remains unknown. However, mutations in the coding sequence of the gene, gene amplification, and gene rearrangement do not account for the high frequency of overexpression of this gene, and the overexpression is not due to an increase in the number of cycling cells.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalMolecular Carcinogenesis
Volume22
Issue number1
DOIs
Publication statusPublished - 1998 May 1
Externally publishedYes

Fingerprint

Peptide Elongation Factor 1
Point Mutation
Colorectal Neoplasms
Carcinoma
Mutation
Pancreatic Neoplasms
Genes
Gene Amplification
Complementary DNA
Cell Count
RNA
Gastrointestinal Neoplasms
Gene Rearrangement
Mutation Rate
Starvation
Southern Blotting
Gene Frequency
Codon
Leucine
Serine

Keywords

  • Colorectal carcinoma
  • Elongation factor-1γ
  • Pancreatic adenocarcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma. / Frazier, Marsha L.; Inamdar, Nikhil; Alvula, Silpa; Wu, Elsie; Kim, Yeul Hong.

In: Molecular Carcinogenesis, Vol. 22, No. 1, 01.05.1998, p. 9-15.

Research output: Contribution to journalArticle

Frazier, Marsha L. ; Inamdar, Nikhil ; Alvula, Silpa ; Wu, Elsie ; Kim, Yeul Hong. / Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma. In: Molecular Carcinogenesis. 1998 ; Vol. 22, No. 1. pp. 9-15.
@article{8240d54dd1f0476ab5c38fc6cb928c8d,
title = "Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma",
abstract = "Elongation factor-1 (EF-1) γ is overexpressed in a high proportion of gastrointestinal cancers. The mechanism of overexpression has not been determined. The purpose of this study was to examine cDNA specimens from pancreatic and colorectal cancer for mutation in this gene, which would allow us to determine whether gene mutations are responsible for overexpression of EF-1γ. In one colorectal carcinoma, we detected an A→G transition at amino- acid codon 158 (T→C in the sense strand) resulting in a change from a leucine to a serine. The base change was not detected in cDNA isolated from normal-appearing tissue from the same patient. We did not find mutations in another five colorectal carcinoma and five pancreatic cancer samples. Thus, although we detected a mutation in one tumor, the frequency of mutations was too low to account for the high frequency of overexpression of the EF-1γ RNA in colorectal cancer. We also investigated other possible mechanisms of overexpression of the EF-1γ RNA in this study. Slot-blot analysis of DNA isolated from colorectal cancers showed that the overexpression was not due to gene amplification. Using serum starvation to synchronize cultured cells, we showed that the overexpression was also not due to an increase in the number of cycling cells, as occurs in cancer. Using Southern blot analysis, we were unable to detect genome rearrangements that could have been responsible for the overexpression. In conclusion, the mechanism for overexpression of the EF-1γ, gene in colorectal and pancreatic cancer remains unknown. However, mutations in the coding sequence of the gene, gene amplification, and gene rearrangement do not account for the high frequency of overexpression of this gene, and the overexpression is not due to an increase in the number of cycling cells.",
keywords = "Colorectal carcinoma, Elongation factor-1γ, Pancreatic adenocarcinoma",
author = "Frazier, {Marsha L.} and Nikhil Inamdar and Silpa Alvula and Elsie Wu and Kim, {Yeul Hong}",
year = "1998",
month = "5",
day = "1",
doi = "10.1002/(SICI)1098-2744(199805)22:1<9::AID-MC2>3.0.CO;2-J",
language = "English",
volume = "22",
pages = "9--15",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma

AU - Frazier, Marsha L.

AU - Inamdar, Nikhil

AU - Alvula, Silpa

AU - Wu, Elsie

AU - Kim, Yeul Hong

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Elongation factor-1 (EF-1) γ is overexpressed in a high proportion of gastrointestinal cancers. The mechanism of overexpression has not been determined. The purpose of this study was to examine cDNA specimens from pancreatic and colorectal cancer for mutation in this gene, which would allow us to determine whether gene mutations are responsible for overexpression of EF-1γ. In one colorectal carcinoma, we detected an A→G transition at amino- acid codon 158 (T→C in the sense strand) resulting in a change from a leucine to a serine. The base change was not detected in cDNA isolated from normal-appearing tissue from the same patient. We did not find mutations in another five colorectal carcinoma and five pancreatic cancer samples. Thus, although we detected a mutation in one tumor, the frequency of mutations was too low to account for the high frequency of overexpression of the EF-1γ RNA in colorectal cancer. We also investigated other possible mechanisms of overexpression of the EF-1γ RNA in this study. Slot-blot analysis of DNA isolated from colorectal cancers showed that the overexpression was not due to gene amplification. Using serum starvation to synchronize cultured cells, we showed that the overexpression was also not due to an increase in the number of cycling cells, as occurs in cancer. Using Southern blot analysis, we were unable to detect genome rearrangements that could have been responsible for the overexpression. In conclusion, the mechanism for overexpression of the EF-1γ, gene in colorectal and pancreatic cancer remains unknown. However, mutations in the coding sequence of the gene, gene amplification, and gene rearrangement do not account for the high frequency of overexpression of this gene, and the overexpression is not due to an increase in the number of cycling cells.

AB - Elongation factor-1 (EF-1) γ is overexpressed in a high proportion of gastrointestinal cancers. The mechanism of overexpression has not been determined. The purpose of this study was to examine cDNA specimens from pancreatic and colorectal cancer for mutation in this gene, which would allow us to determine whether gene mutations are responsible for overexpression of EF-1γ. In one colorectal carcinoma, we detected an A→G transition at amino- acid codon 158 (T→C in the sense strand) resulting in a change from a leucine to a serine. The base change was not detected in cDNA isolated from normal-appearing tissue from the same patient. We did not find mutations in another five colorectal carcinoma and five pancreatic cancer samples. Thus, although we detected a mutation in one tumor, the frequency of mutations was too low to account for the high frequency of overexpression of the EF-1γ RNA in colorectal cancer. We also investigated other possible mechanisms of overexpression of the EF-1γ RNA in this study. Slot-blot analysis of DNA isolated from colorectal cancers showed that the overexpression was not due to gene amplification. Using serum starvation to synchronize cultured cells, we showed that the overexpression was also not due to an increase in the number of cycling cells, as occurs in cancer. Using Southern blot analysis, we were unable to detect genome rearrangements that could have been responsible for the overexpression. In conclusion, the mechanism for overexpression of the EF-1γ, gene in colorectal and pancreatic cancer remains unknown. However, mutations in the coding sequence of the gene, gene amplification, and gene rearrangement do not account for the high frequency of overexpression of this gene, and the overexpression is not due to an increase in the number of cycling cells.

KW - Colorectal carcinoma

KW - Elongation factor-1γ

KW - Pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0031833627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031833627&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2744(199805)22:1<9::AID-MC2>3.0.CO;2-J

DO - 10.1002/(SICI)1098-2744(199805)22:1<9::AID-MC2>3.0.CO;2-J

M3 - Article

VL - 22

SP - 9

EP - 15

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 1

ER -